Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapiesChristopher J. Lewis, Stephen E. Attwood, Susan Pritchard et al.|Surgical Endoscopy|2011Cited by 14
Reply to Letter to the Editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First)Sri G. Thrumurthy, Stephen E. Attwood, Christopher J. Lewis et al.|Surgical Endoscopy|2011Cited by 0